Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study

NCT00911521 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: human papillomavirus vaccination (Gardasil)

Sponsor

Tuen Mun Hospital